Кардиоваскулярная терапия и профилактика (Dec 2023)

Dyslipidemia in the Russian Federation: population data, associations with risk factors

  • O. M. Drapkina,
  • A. E. Imaeva,
  • V. A. Kutsenko,
  • A. V. Kapustina,
  • Yu. A. Balanova,
  • S. A. Maksimov,
  • G. A. Muromtseva,
  • M. B. Kotova,
  • N. S. Karamnova,
  • S. E. Evstifeeva,
  • O. A. Litinskaya,
  • M. S. Pokrovskaya,
  • N. A. Imaeva,
  • E. M. Filichkina,
  • O. E. Ivlev,
  • G. E. Svinin,
  • L. I. Gomanova,
  • Yu. V. Doludin,
  • I. A. Efimova,
  • A. L. Borisova,
  • B. M. Nazarov,
  • E. B. Yarovaya,
  • T. V. Repkina,
  • T. O. Gonoshilova,
  • A. V. Kudryavtsev,
  • N. I. Belova,
  • L. L. Shagrov,
  • M. A. Samotrueva,
  • A. L. Yasenyavskaya,
  • E. N. Chernysheva,
  • S. V. Glukhovskaya,
  • I. A. Levina,
  • E. A. Shirshova,
  • E. B. Dorzhieva,
  • E. Z. Urbanova,
  • N. Yu. Borovkova,
  • V. K. Kurashin,
  • A. S. Tokareva,
  • Yu. I. Ragino,
  • G. I. Simonova,
  • V. S. Shramko,
  • V. N. Nikulin,
  • O. R. Aslyamov,
  • G. V. Khokhlova,
  • A. V. Solovyova,
  • A. A. Rodionov,
  • O. V. Kryachkova,
  • Yu. Yu. Shamurova,
  • I. V. Tantsyreva,
  • I. N. Baryshnikova,
  • M. G. Ataev,
  • M. O. Radjabov,
  • M. M. Isakhanova,
  • M. A. Umetov,
  • L. V. Elgarova,
  • I. A. Khakuasheva,
  • E. I. Yamashkina,
  • M. V. Esina,
  • T. A. Kunyaeva,
  • A. M. Nikitina,
  • N. V. Savvina,
  • Yu. E. Spiridonova,
  • E. A. Naumova,
  • A. A. Keskinov,
  • V. S. Yudin,
  • S. M. Yudin,
  • A. V. Kontsevaya,
  • S. A. Shalnova

DOI
https://doi.org/10.15829/1728-8800-2023-3791
Journal volume & issue
Vol. 22, no. 8S

Abstract

Read online

Aim. To study the prevalence of dyslipidemias and their association with various risk factors in the Russian population of men and women aged 35-74 years in 2020-2022.Material and methods. This work was carried out as part of the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3) study. The sample included 28731 men and women aged 35-74 years living in 15 Russian regions. Hypercholesterolemia (HC) was diagnosed with total cholesterol (TC) ≥5,0 mmol/l, while elevated low-density lipoprotein cholesterol (LDL-C) was considered ≥3,0 mmol/l, hypertriglyceridemia — with triglyceride levels ≥1,7 mmol/l, reduced high-density lipoprotein cholesterol (HDL-C) <1,0 mmol/l in men and <1,2 mmol/l in women. Associations were assessed using logistic regression after adjustment for socio-demographic characteristics, drinking status, presence of hypertension (HTN) and stroke.Results. The prevalence of hypertriglyceridemia in the Russian Federation in 2020-2022 was 58,8%, hypertriglyceridemia — 32,2%. The incidence of lipid-lowering therapy increased with age from 1% in the group of 35-44 years to 16% in the group of 65-74 years. On average, only 7,6% of study participants received lipid-lowering therapy. Significant associations of HC with HTN, obesity and alcohol abuse were identified. Similar results were obtained for elevated LDL-C levels, with the exception of alcohol abuse. In turn, a reduced HDL-C level was significantly associated with the lack of higher education, marriage, physical activity, smoking and the presence of diseases.Conclusion. The prevalence of lipid disorders in the Russian Federation in 2020-2022 remained at a high level. These disorders occurred more often in women, and they were better informed about their cholesterol levels and more often received lipid-lowering therapy. HTN, obesity, and some behavioral and social risk factors were associated with dyslipidemia.

Keywords